Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

IMPORTANCE: A pathologic complete response (pCR; no invasive or in situ cancer) occurs in 40% to 50% of patients with HER2-positive (HER2+) and triple-negative (TN) breast cancer. The need for surgery if percutaneous biopsy of the breast after neoadjuvant chemotherapy (NCT) indicates pCR in the brea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Surg
Main Authors: Tadros, Audree B., Yang, Wei T., Krishnamurthy, Savitri, Rauch, Gaiane M., Smith, Benjamin D., Valero, Vicente, Black, Dalliah M., Lucci, Anthony, Caudle, Abigail S., DeSnyder, Sarah M., Teshome, Mediget, Barcenas, Carlos H., Miggins, Makesha, Adrada, Beatriz E., Moseley, Tanya, Hwang, Rosa F., Hunt, Kelly K., Kuerer, Henry M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5547923/
https://ncbi.nlm.nih.gov/pubmed/28423171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2017.0562
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados